Variant to Function Symposium | Keynote: Placing billion-dollar bets: human genetics in drug R&D
About the Variant to Function (V2F) Symposium
The Variant to Function (V2F) Symposium is a one-day scientific conference held at the Ó³»´«Ã½â€™s Merkin Lobby and Auditorium. Hosted by the Novo Nordisk Foundation Center for Genomic Mechanisms of Disease, this symposium dives into the critical challenge of translating genetic associations into actionable therapeutic targets, including biomarkers and assays for patient stratification.
Co-chaired by Melina Claussnitzer and Kasper Lage, this event showcases a day of high-impact science and cross-disciplinary discussions aimed at accelerating genetically-informed approaches in healthcare.
Keynote: Placing billion-dollar bets: human genetics in drug R&D
Robert Plenge, MD, PhD
Executive Vice President and Chief Research Officer
Bristol Myers Squibb